5:54 PM ET
Form 4
Insider Selling
Enliven Therapeutics CFO Benjamin Hohl Sells $232K of Stock
Benjamin Hohl, CFO, sold 6,018 shares of Enliven Therapeutics, Inc. at $38.48 a share, worth $232K in total on Oct 19, 2026. Shares held after the trade: 38,000 (-13.7%).
- Value
- $232K
- Shares
- 6,018
- Price
- $38.48
- Role
- CFO
- Holding change
- -13.7%
- Trade date
- Oct 19, 2026